SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-20-305790
Filing Date
2020-11-30
Accepted
2020-11-30 17:28:52
Documents
4

Document Format Files

Seq Description Document Type Size
1 424B5 d23694d424b5.htm 424B5 680924
2 GRAPHIC g23694g10y41.jpg GRAPHIC 40007
3 GRAPHIC g23694g15u63.jpg GRAPHIC 39208
4 GRAPHIC g23694g45h88.jpg GRAPHIC 103366
  Complete submission text file 0001193125-20-305790.txt   926497
Mailing Address 200 CAMBRIDGE PARK DRIVE SUITE 3100 CAMBRIDGE MA 02140
Business Address 200 CAMBRIDGE PARK DRIVE SUITE 3100 CAMBRIDGE MA 02140 617-945-5576
Cogent Biosciences, Inc. (Filer) CIK: 0001622229 (see all company filings)

IRS No.: 465308248 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-230678 | Film No.: 201359096
SIC: 2834 Pharmaceutical Preparations